Attenuation of Experimental Atherosclerosis by Interleukin-19

OBJECTIVE: Interleukin-19 (IL-19) is putative Th2, anti-inflammatory interleukin. Its expression in, and potential role in atherogenesis is unknown. IL-19 is not detected in normal artery, and is expressed to a greater degree in plaque from symptomatic vs. asymptomatic patients, suggesting a compens...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ellison, Stephen, Gabunia, Khatuna, Kelemen, Sheri E., England, Ross N., Scalia, Rosario, Richards, James M., Orr, Wayne, Traylor, James G., Rogers, Thomas, Cornwell, William, Berglund, Lisa M., Goncalves, Isabel, Gomez, Maria F., Autieri, Michael V.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3950941/
https://ncbi.nlm.nih.gov/pubmed/23950143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.113.301521
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados